Head and neck cancers often come back after initial treatment, leading to poorer outcomes for patients. Treatments for recurrent cancer are largely ineffective, often as a result of changes to the tumour microenvironment which can weaken the body's immune response against the cancer. Our research will explore why immune cells fail to fight recurrent head and neck cancer and will develop innovative treatments to reprogram these cells and boost their anti-cancer activity.